Equities

Krishna Institute of Medical Sciences Ltd

Krishna Institute of Medical Sciences Ltd

Actions
Health CareHealth Care Providers
  • Price (INR)559.20
  • Today's Change4.20 / 0.76%
  • Shares traded31.49k
  • 1 Year change+50.24%
  • Beta0.4369
Data delayed at least 15 minutes, as of Nov 14 2024 04:04 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in INRIncome statement in INRView more

Year on year Krishna Institute of Medical Sciences Ltd had net income fall -7.78% from 3.36bn to 3.10bn despite a 13.67% increase in revenues from 21.98bn to 24.98bn. An increase in the selling, general and administrative costs as a percentage of sales from 25.68% to 27.10% was a component in the falling net income despite rising revenues.
Gross margin79.37%
Net profit margin13.45%
Operating margin20.03%
Return on assets9.10%
Return on equity17.37%
Return on investment11.33%
More ▼

Cash flow in INRView more

In 2024, cash reserves at Krishna Institute of Medical Sciences Ltd fell by 147.20m. However, the company earned 5.21bn from its operations for a Cash Flow Margin of 20.86%. In addition the company generated 2.17bn cash from financing while 7.53bn was spent on investing.
Cash flow per share13.13
Price/Cash flow per share42.22
Book value per share50.03
Tangible book value per share38.91
More ▼

Balance sheet in INRView more

Krishna Institute of Medical Sciences Ltd has a Debt to Total Capital ratio of 43.84%, a lower figure than the previous year's 49.71%.
Current ratio0.9499
Quick ratio0.8678
Total debt/total equity0.8903
Total debt/total capital0.4384
More ▼

Growth rates in INR

Year on year, growth in earnings per share excluding extraordinary items dropped -7.78%.
EPS growth(5 years)--
EPS (TTM) vs
TTM 1 year ago
-3.19
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.